Abstract
Get full access to this article
View all access options for this article.
References
1.Pfizer . Pfizer Announces Positive Topline Results From Phase 3 Study of Hemophilia A Gene Therapy Candidate . July 24, 2024 . Available from: https://www.pfizer.com/news/press-release/press-release-detail/pfizer-announces-positive-topline-results-phase-3-study [Last accessed:
August 12 , 2024
].
2.Pfizer DMD Gene Therapy Team . Letter to Parent Project Muscular Dystrophy . July 30, 2024 . Available from: https://www.parentprojectmd.org/pfizer-discontinues-development-of-investigational-mini-dystrophin-gene-therapy/ [Last accessed:
August 14 , 2024
].
3.Sangamo Therapeutics . Sangamo Therapeutics Announces Global Epigenetic Regulation and Capsid Delivery License Agreement with Genentech to Develop Novel Genomic Medicines for Neurodegenerative Diseases . August 6, 2024 . Available from: https://investor.sangamos.com/news-releases/news-release-details/sangamo-therapeutics-announces-global-epigenetic-regulation-and [Last accessed:
August 12 , 2024
].
4.Orum Therapeutics . Orum Therapeutics Announces a Global, Multi-Target License and Option Agreement with Vertex for the Use of Orum’s TPD2® Technology to Develop Novel Degrader-Antibody Conjugates . July 16, 2024 . Available from: https://www.orumrx.com/news/orum-therapeutics-announces-a-global-multi-target-license-and-option-agreement-with-vertex-for-the-use-of-orums-tpd-technology-to-develop-novel-degrader-antibody-conjugates [Last accessed:
August 14 , 2024
].
5.
Philippidis
A
. Replacing Chemo: Vertex, Orum Launch Up to $945M+ DAC Collaboration . Genetic Engineering & Biotechnology News . July 16, 2024 . Available from: https://www.genengnews.com/topics/drug-discovery/replacing-chemo-vertex-orum-launch-up-to-945m-dac-collaboration/ [Last accessed:
August 14 , 2024
].
6.Evotec . Evotec SE reports H1 2024 results: Challenging Year; Priority Reset for Sustainable Profitable Growth Gaining Momentum, Building on Core Strengths . August 14, 2024 . Available from: https://www.evotec.com/uploads/download-files/PR_2024-08-14_Evotec_H1_results_e.pdf [Last accessed:
August 14 , 2024
].
7.GEMMA Biotherapeutics and Franklin Biolabs . To Further Advance Gene Therapy Research, Industry Pioneer Jim Wilson is Forming Two Independent Companies Dedicated to Genetic Medicine . July 31, 2024 . Available from: https://www.prnewswire.com/news-releases/to-further-advance-gene-therapy-research-industry-pioneer-jim-wilson-is-forming-two-independent-companies-dedicated-to-genetic-medicine-302211669.html [Last accessed:
August 14 , 2024
].
8.Passage Bio . Passage Bio Out-licenses Three Pediatric Gene Therapy Programs to GEMMA Biotherapeutics and Enters New Research Collaboration . August 1, 2024 . Available from: https://www.passagebio.com/investors-and-news/press-releases-and-statements/news-details/2024/Passage-Bio-Out-licenses-Three-Pediatric-Gene-Therapy-Programs-to-GEMMA-Biotherapeutics-and-Enters-New-Research-Collaboration/default [Last accessed:
August 14 , 2024
].
9.BioMarin Pharmaceutical . BioMarin Announces 20% Y/Y Total Revenue Growth in the Second Quarter and Increase in Full-year 2024 Guidance . August 5, 2024 . Available from: https://investors.biomarin.com/news/news-details/2024/BioMarin-Announces-20-YY-Total-Revenue-Growth-in-the-Second-Quarter-and-Increase-in-Full-year-2024-Guidance/default.aspx [Last accessed:
August 12 , 2024
].